Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Velcade

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Velcade was produced by Johnson & Johnson and Takeda.

In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa

In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa

Velcade (bortezomib), and have disease progression.

After FDA refusal, Takeda builds case for subcutaneous Entyvio

After FDA refusal, Takeda builds case for subcutaneous Entyvio growth back on track after losing patent protection for its big-selling multiple myeloma drug  Velcade (bortezomib).

FDA fast-tracks GSK’s anti-BCMA drug for multiple myeloma

FDA fast-tracks GSK’s anti-BCMA drug for multiple myeloma The study participants had on average received seven earlier lines of therapy, including an immuno-modulatory drug such as Celgene’s Revlimid (lenalidomide), a proteasome inhibitor such as Takeda’s Velcade

Takeda’s subcutaneous Entyvio formulation faces FDA rejection

Takeda’s subcutaneous Entyvio formulation faces FDA rejection The anti-integrin antibody Entyvio (vedolizumab) is an important growth products for Takeda as it faces loss of patent protection in the US for its blockbuster multiple myeloma drug Velcade (bortezomib).

GSK files anti-BCMA drug for myeloma after second trial win

GSK files anti-BCMA drug for myeloma after second trial win Velcade (bortezomib), and Johnson &Johnson’s anti-CD38 antibody Darzalex (daratumumab).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
Responding to dynamic shifts in value communications
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
Doing what we can and having fun doing it: our fundraising month
Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...

Infographics